HOS and its ePRISM® solution represent truly personalized healthcare. ePRISM® identifies a patient's specific risk of procedural complications, allowing the clinician to select the intervention, devices and drug therapies that lead to the best outcome for that individual patient. It's evidence–based medicine made personal.
The HOS risk engine was designed to be care–agnostic. Risk models based on peer reviewed evidence or a hospital's own patient population can be used. The peer reviewed risk models are based on national bodies of evidence and are sponsored by prestigious organizations, such as:
– The American College of Cardiology (25–year exclusive relationship with HOS)
– The Heart Rhythm Society
– The American College of Surgeons
– The Society of Thoracic Surgeons
Through important partnerships with research organizations, HOS provides actionable data, at the point of care, that historically has been used for research purposes only.
Click the title to read full article.American Heart Association Late-Breaking Clinical Trial Report New Predictive Modeling Tool Helps Identify High-Risk PCI Patients at Point of Care New Product Announcement ePRISM® and Saint Luke’s Hospital, Kansas City nominated as finalist for ClearMark Award HOS and ACC form Strategic Partnership HOS Announces New President & Chief Sales & Marketing Officer HOS Announces New CEO PRESS - A New Consent Form PRESS - Heart Stents PRESS - Risks More Clear Through New Consent Form PRESS - Calculating risks of cardiac treatments PRESS - Amerinet Puts HOS on Contracted Supplier List